Aceglatone
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(3R,3aR,6S,6aR)-2,5-Dioxohexahydrofuro[3,2-b]furan-3,6-diyl diacetate | |
| Clinical data | |
| Trade names | Glucaron |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number |
642-83-1 |
| ATC code | none |
| PubChem | CID 636372 |
| ChemSpider |
599998 |
| UNII |
347Q3OOJ13 |
| ChEMBL |
CHEMBL2103781 |
| Synonyms |
D-Glucaric acid di-γ-lactone 2,5-diacetate 2,5-Di-O-acetyl-D-glucaro-1,4:6,3-dilactone 2,5-Di-O-acetyl-D-glucosaccharo-1,4:6,3-dilactone |
| Chemical data | |
| Formula | C10H10O8 |
| Molar mass | 258.18 g/mol |
| |
| |
| Physical data | |
| Melting point | 185 to 186 °C (365 to 367 °F) [1] |
| | |
Aceglatone (Glucaron) is an antineoplastic drug available in Japan.[2]
It is an inhibitor of the enzyme β-glucuronidase.[3]
References
- ↑ Merck Index, 11th Edition, 20
- ↑ Glucaron, drugs.com
- ↑ Iida, Ryohei; Nagata, Sachiko; Kakimoto, Morio; Akaike, Hiroaki; Watanabe, Hiroko; Shioya, Akitoshi (1965). "2,5-Di-O-acetyl-D-glucosaccharo-(1→4)(6→3)-dilactone, a new potent β-glucuronidase inhibitor". Japanese Journal of Pharmacology 15 (1): 88–90. doi:10.1254/jjp.15.88.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
